Trials that use: Risk difference
New to this method? Read the tutorial →
6,276 results
- RETRIEVE-AMIIndependent statistical analysis of RETRIEVE-AMI Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05307965).
- Retrospective Encore Reverse Shoulder Prosthesis Study: Complete Statistical AnalysisIndependent statistical analysis of Retrospective Encore Reverse Shoulder Prosthesis Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00765037).
- RetroTIFIndependent statistical analysis of Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- REVEALIndependent statistical analysis of Evaluation of AMG 714 for Vitiligo: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04338581).
- REVEALIndependent statistical analysis of REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01252953).
- REVEAL 1Independent statistical analysis of REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Reveal In-Office Implants: Complete Statistical AnalysisIndependent statistical analysis of Reveal In-Office Implants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01168427).
- Reveal LINQ for Chronic Obstructive Pulmonary Disease (COPD): Complete Statistical AnalysisIndependent statistical analysis of Reveal LINQ for Chronic Obstructive Pulmonary Disease (COPD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04169529).
- REVEALPLAQUEIndependent statistical analysis of The REVEALPLAQUE Study: A pRospEctiVe, multicEnter Study to AnaLyze PLAQUE Using CCTA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- REVELUTIONIndependent statistical analysis of RElugolix VErsus LeUprolide Cardiac Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05320406).
- Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib: Complete Statistical AnalysisIndependent statistical analysis of Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01466972).
- REVIRAL 1Independent statistical analysis of A Study to Learn About the Effects of Sisunatovir in Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infection.: primary endpoint results, effect estimate with confidence interval, sample-size…
- Revlimid in Transfusion Dependent Patients: Complete Statistical AnalysisIndependent statistical analysis of Revlimid in Transfusion Dependent Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01178814).
- Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01600053).
- RHA® Redensity Eye Versus No-treatment for the Infra-Orbital Hollows: Complete Statistical AnalysisIndependent statistical analysis of RHA® Redensity Eye Versus No-treatment for the Infra-Orbital Hollows: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04577898).
- RHINEIndependent statistical analysis of A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Ri-CoDIFy 3Independent statistical analysis of Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04802837).
- RI-US XLIndependent statistical analysis of Resolute Integrity US Extended Length Sub-Study(RI US XL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01913600).
- RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy – A Randomized, Controlled Trial: Complete Statistical AnalysisIndependent statistical analysis of RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- RICHIndependent statistical analysis of Repair of Infected or Contaminated Hernias: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00617357).
- Ridaforolimus With Cetuximab: Adv Non-Small Cell Lung, Colorectal, Head & Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Ridaforolimus With Cetuximab: Adv Non-Small Cell Lung, Colorectal, Head & Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Ridge Preservation After Tooth Extraction Using Cortical Versus Cancellous Freeze Dried Bone Allograft: Complete Statistical AnalysisIndependent statistical analysis of Ridge Preservation After Tooth Extraction Using Cortical Versus Cancellous Freeze Dried Bone Allograft: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RIGHT: Rhythm ID Going Head-to-Head Trial: Complete Statistical AnalysisIndependent statistical analysis of RIGHT: Rhythm ID Going Head-to-Head Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00148954).
- RILECSUIndependent statistical analysis of Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine: primary endpoint results, effect estimate with confidence interval, sample-size…
- Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder: Complete Statistical AnalysisIndependent statistical analysis of Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00523718).
- Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum Disorders: Complete Statistical AnalysisIndependent statistical analysis of Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- RIPCOM1Independent statistical analysis of The Right Ventricular Pulmonary Circulation Continuum in Mitral Valve Disease Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- RISE AdultIndependent statistical analysis of RISE Adult Medication Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01779362).
- RISE-MIndependent statistical analysis of Radiotherapy With Immunotherapy for Systemic Effect in Myeloma (RISE-M): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03634800).
- Risk Stratification to Promote Effective Shared Decision-Making for Colorectal Cancer Screening: Complete Statistical AnalysisIndependent statistical analysis of Risk Stratification to Promote Effective Shared Decision-Making for Colorectal Cancer Screening: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Rituximab and ABVD for Hodgkin’s Patients: Complete Statistical AnalysisIndependent statistical analysis of Rituximab and ABVD for Hodgkin's Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00504504).
- Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Rituximab and Pembrolizumab With or Without Lenalidomide in Treating Patients With Relapsed Follicular Lymphoma and Diffuse Large B-Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Rituximab and Pembrolizumab With or Without Lenalidomide in Treating Patients With Relapsed Follicular Lymphoma and Diffuse Large B-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size…
- Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Rituximab Plus Lenalidomide in Patients With Mucosa Associated Lymphoid Tissue: Complete Statistical AnalysisIndependent statistical analysis of Rituximab Plus Lenalidomide in Patients With Mucosa Associated Lymphoid Tissue: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01611259).
- Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma: primary endpoint results, effect estimate with confidence interval,…
- RN-Led Palliative and Supportive Care Intervention: Complete Statistical AnalysisIndependent statistical analysis of RN-Led Palliative and Supportive Care Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04570709).
- Robotic Arm Assisted Total Knee Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Robotic Arm Assisted Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02058069).
- Robotic Pedaling Therapy for Targeted Neural Plasticity: Complete Statistical AnalysisIndependent statistical analysis of Robotic Pedaling Therapy for Targeted Neural Plasticity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03300258).
- Robotic Single Port Donor Nephrectomy: Complete Statistical AnalysisIndependent statistical analysis of Robotic Single Port Donor Nephrectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01925677).
- ROCKETIndependent statistical analysis of A Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Role of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biopsy Proven Atypical Ductal Hyperplasia: Complete Statistical AnalysisIndependent statistical analysis of Role of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biopsy Proven Atypical Ductal Hyperplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Role of Everolimus in Highly Sensitized Patients: Complete Statistical AnalysisIndependent statistical analysis of Role of Everolimus in Highly Sensitized Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01911546).
- Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA): Complete Statistical AnalysisIndependent statistical analysis of Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01198509).
- Role of Pancreatic Triglyceride Content in Beta-cell Function: Complete Statistical AnalysisIndependent statistical analysis of Role of Pancreatic Triglyceride Content in Beta-cell Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00602953).
- Role of Soy Supplementation in Prostate Cancer Development: Complete Statistical AnalysisIndependent statistical analysis of Role of Soy Supplementation in Prostate Cancer Development: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00255125).
- Roll-over Study to Assess Safety of Lixivaptan in Participants With ADPKD Who Completed Study PA-ADPKD-303: Complete Statistical AnalysisIndependent statistical analysis of Roll-over Study to Assess Safety of Lixivaptan in Participants With ADPKD Who Completed Study PA-ADPKD-303: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Rollover Study of BMS-354825 in Patients With CML and Ph+ALL: Complete Statistical AnalysisIndependent statistical analysis of Rollover Study of BMS-354825 in Patients With CML and Ph+ALL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01030718).